Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 19, 2001

Primary Completion Date

February 28, 2007

Study Completion Date

May 27, 2011

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
BIOLOGICAL

sargramostim

DRUG

cyclophosphamide

DRUG

cyclosporine

DRUG

fludarabine phosphate

DRUG

melphalan

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (12)

10466

MBCCOP-Our Lady of Mercy Cancer Center, The Bronx

19104

Abramson Cancer Center at the University of Pennsylvania, Philadelphia

32224

Mayo Clinic - Jacksonville, Jacksonville

44109

MetroHealth's Cancer Care Center at MetroHealth Medical Center, Cleveland

55905

Mayo Clinic Cancer Center, Rochester

32207-8554

Baptist Cancer Institute - Jacksonville, Jacksonville

02111

Cancer Center at Tufts - New England Medical Center, Boston

02215

Beth Israel Deaconess Medical Center, Boston

07601

CCOP - Northern New Jersey, Hackensack

08903

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick

44106-5065

Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University, Cleveland

17033-0850

Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00014508 - Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter